• Skip to primary navigation
  • Skip to main content
Engineered Tissue Solutions

Engineered Tissue Solutions

  • Chronic Wound Care
    • Mirragen
    • Clinical Evidence
    • ETS Case Studies
    • Testimonials
  • Surgical Wound Care
    • MirraSurg
    • Clinical Evidence
    • ETS Case Studies
    • Testimonials
  • Science & Technology
  • Provider & Patient Support
    • For Providers
    • For Patients
    • Reimbursement
  • About
    • Contact Us
    • News & Events
    • Careers
    • Testimonials
  • Request Information

Reaching Closure with Mirragen®, a Bioactive Glass Fiber Matrix

Join us for an exclusive dinner and discussion to learn about how Mirragen,
a bioactive glass fiber matrix, facilitates quality tissue formation without the
typical risks of tissue-based products, all in an easy to use versatile format.

Speakers:
Dr. Donald William Buck II, MD (CMO of ETS)
Dr. Steven Jung, Ph.D. (CTO of ETS and Inventor of Mirragen)
Dr. Ralph J. Napolitano Jr., DPM, CWSP, FACFAS

Please RSVP by September 30.

We look forward to an evening of insightful conversation.

RSVP NOW
RSVP Now

Location

Mr. Chow – Caesars Palace
3570 Las Vegas Blvd S, Las Vegas, NV 89109, USA

Date & Time

October 3, 2024
7:00 PM (PT)

RSVP – Reaching Closure with Mirragen, a Bioactive Glass Fiber Matrix

Loading

Learn how ETS is transforming wound care.

Access Literature
  • Request Information
  • Contact Us
  • Careers
  • LinkedIn
  • Facebook
  • Instagram
  • Disclaimer
  • Privacy
  • Terms & Conditions
  • Patents

MIRRAGEN® is a registered trademark of ETS Tech Holdings, LLC. | © ETS Wound Care